Drug intelligence / Profile preview

TAI

Development stage
Unknown
Lead developer
Yantai Rongchang Pharmaceutical
Modality
Small Molecules
Administration
Rectal, Intra-arterial, Topical
01

Overview

"TAI" is a non-specific term that, in the provided clinical contexts, refers to two distinct entities. In oncology, particularly in trials involving non-small cell lung cancer (NSCLC), it is a common abbreviation for **Transcatheter Arterial Infusion**, a localized drug delivery procedure used to administer chemotherapy directly into the blood vessels supplying a tumor. In the context of proctology and traditional Chinese medicine (TCM), "TAI" (often appearing as "Anal Tai" or "Gangtai") refers to **Gangtai** (肛泰), a branded multi-ingredient herbal formulation used to treat hemorrhoids, anal fissures, and anal sinusitis. The Gangtai formulation typically includes ingredients such as *Sanguisorba officinalis* (Burnet), *Galla Chinensis*, *Borneol*, *Berberine Hydrochloride*, and *Papaverine Hydrochloride*, which collectively exert anti-inflammatory, analgesic, hemostatic, and antispasmodic effects.

Brand names
GangtaiAnal Tai
Other names
Transcatheter Arterial InfusionGangtai Suppository肛泰
02

Targets

PDE (Phosphodiesterase family)

Beyond the preview

Go deeper on TAI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAI.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call